drugset / Trial / NCT02056236

Summary

The purpose of this study is to estimate the effect of medical treatment of electro-encephalographic status epilepticus on neurological outcome of patients with postanoxic encephalopathy after cardiac arrest.

Timeline

Start
2014-04
Primary completion
2021-04-24
Completion
2022-01-24

Outcome

Missed primary endpoint

paper At 3 months, 79 of 88 patients (90%) in the antiseizure-treatment group and 77 of 84 patients (92%) in the control group had a poor outcome (difference, 2 percentage points; 95% confidence interval, -7 to 11; P = 0.68). PMID 35196426 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 1000 mg Intravenous
Subject Lorazepam Small molecule — —
Subject Midazolam Small molecule — —
Subject Phenytoin Unknown 150 mg Intravenous
Subject Propofol Small molecule 8 mg/kg —
Subject Thiopental Small molecule 5 mg/kg —
Subject Valproic Acid Small molecule 15 mg/kg Intravenous

Indications